false Q1 --12-31 0001042187 0001042187 2026-01-01 2026-03-31 0001042187 2026-05-13 0001042187 2026-03-31 0001042187 2025-12-31 0001042187 us-gaap:NonrelatedPartyMember 2026-03-31 0001042187 us-gaap:NonrelatedPartyMember 2025-12-31 0001042187 us-gaap:RelatedPartyMember 2026-03-31 0001042187 us-gaap:RelatedPartyMember 2025-12-31 0001042187 us-gaap:SeriesEPreferredStockMember 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001042187 us-gaap:SeriesFPreferredStockMember 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember 2025-12-31 0001042187 2025-10-01 2025-10-01 0001042187 2025-01-01 2025-03-31 0001042187 2024-12-31 0001042187 2025-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001042187 us-gaap:CommonStockMember 2025-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001042187 us-gaap:RetainedEarningsMember 2025-12-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-12-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001042187 us-gaap:CommonStockMember 2024-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001042187 us-gaap:RetainedEarningsMember 2024-12-31 0001042187 us-gaap:TreasuryStockCommonMember 2024-12-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001042187 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001042187 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001042187 us-gaap:CommonStockMember 2026-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001042187 us-gaap:RetainedEarningsMember 2026-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001042187 us-gaap:CommonStockMember 2025-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001042187 us-gaap:RetainedEarningsMember 2025-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-03-31 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:NewCreditAgreementsMember 2025-09-30 0001042187 YHGJ:NewCreditAgreementsMember YHGJ:TermLoanMember 2025-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember YHGJ:LineFinancialMember 2021-09-30 0001042187 YHGJ:TermLoanFacilityMember YHGJ:LineFinancialAgreementMember YHGJ:LineFinancialMember 2021-09-30 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember 2026-03-31 0001042187 YHGJ:LineFinancialAgreementMember YHGJ:TermLoanMember 2026-03-31 0001042187 YHGJ:LineFinancialAgreementMember 2021-11-01 0001042187 YHGJ:LineFinancialAgreementMember 2021-11-01 2021-11-01 0001042187 YHGJ:LineFinancialAgreementMember 2021-09-30 2021-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2023-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2023-09-30 0001042187 2023-09-30 0001042187 YHGJ:LineFinancialAgreementMember 2023-09-29 2023-09-30 0001042187 YHGJ:TermLoanMember 2026-03-31 0001042187 YHGJ:TermLoanMember 2025-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember 2026-03-31 0001042187 us-gaap:RevolvingCreditFacilityMember 2025-12-31 0001042187 YHGJ:JohnHSchwanMember 2023-12-31 0001042187 YHGJ:JohnHSchwanMember 2024-01-01 2024-01-31 0001042187 YHGJ:JohnHSchwanMember 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:WarrantMember 2026-03-31 0001042187 us-gaap:WarrantMember 2025-12-31 0001042187 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001042187 YHGJ:TwoThousandAndTwentyFourWarrantsMember 2026-03-31 0001042187 us-gaap:PreferredStockMember 2026-03-31 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2025-12-31 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2026-01-01 2026-03-31 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2026-03-31 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001042187 YHGJ:JohnHSchwanMember 2025-12-31 0001042187 YHGJ:IcyMelonLLCMember 2025-01-13 2025-01-13 0001042187 YHGJ:IcyMelonLLCMember 2026-01-01 2026-03-31 0001042187 YHGJ:IcyMelonLLCMember 2025-01-01 2025-03-31 0001042187 YHGJ:IcyMelonLLCMember 2026-03-31 0001042187 YHGJ:IcyMelonLLCMember 2025-12-31 0001042187 srt:MinimumMember 2026-03-31 0001042187 srt:MaximumMember 2026-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure YHGJ:Integer YHGJ:Customer YHGJ:segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________to__________

 

Commission File Number

000-23115

 

YUNHONG GREEN CTI LTD.

(Exact name of registrant as specified in its charter)

 

Illinois   36-2848943
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

22160 N. Pepper Road    
Barrington, Illinois   60010
(Address of principal executive offices)   (Zip Code)

 

(847)382-1000

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, no par value per share   YHGJ   The Nasdaq Stock Market LLC
        (The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of shares outstanding of the registrant’s common stock, no par value per share, as of May 13, 2026 was 2,609,244 (excluding treasury shares).

 

 

 

   

 

 

INDEX

 

PART I – FINANCIAL INFORMATION  
     
Item No. 1. Financial Statements  
  Unaudited Condensed Consolidated Balance Sheets at March 31, 2026 and December 31, 2025 1
  Unaudited Condensed Consolidated Statements of Income (Loss) for the three months ended March 31, 2026 and 2025 2
  Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 3
  Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three months ended March 31, 2026 and 2025 4
  Notes to Unaudited Condensed Consolidated Financial Statements 5
Item No. 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
Item No. 3 Quantitative and Qualitative Disclosures Regarding Market Risk 14
Item No. 4 Controls and Procedures 14
     
PART II – OTHER INFORMATION  
     
Item No. 1 Legal Proceedings 16
Item No. 1A Risk Factors 16
Item No. 2 Unregistered Sales of Equity Securities and Use of Proceeds 16
Item No. 3 Defaults Upon Senior Securities 16
Item No. 4 Mine Safety Disclosures 16
Item No. 5 Other Information 16
Item No. 6 Exhibits 17
  Signatures 18
  Exhibit 31.1  
  Exhibit 31.2  
  Exhibit 32  

 

   
Table of Contents

 

Yunhong Green CTI, Ltd

Unaudited Condensed Consolidated Balance Sheets

 

   March 31,   December 31, 
   2026   2025 
         
ASSETS          
Current assets:          
Cash and cash equivalents  $178,000   $97,000 
Accounts receivable, net   6,109,000    5,955,000 
Inventories   8,006,000    8,738,000 
Prepaid expenses   238,000    283,000 
           
Total current assets   14,531,000    15,073,000 
           
Property, plant and equipment:          
Machinery and equipment   21,993,000    21,993,000 
Office furniture and equipment   2,122,000    2,122,000 
Intellectual property   783,000    783,000 
Leasehold improvements   39,000    39,000 
Fixtures and equipment   518,000    518,000 
Projects under construction   167,000    140,000 
Property, plant and equipment gross    25,622,000    25,595,000 
Less: accumulated depreciation and amortization   (21,749,000)   (21,599,000)
           
Total property, plant and equipment, net   3,873,000    3,996,000 
           
Other assets:          
Operating lease right-of-use   3,242,000    3,393,000 
           
Total other assets   3,242,000    3,393,000 
           
TOTAL ASSETS  $21,646,000   $22,462,000 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Trade payables  $1,782,000   $1,677,000 
Line of credit   6,708,000    6,822,000 
Notes payable – current portion   149,000    146,000 
Notes payable related party   344,000    344,000 
Operating lease liabilities – current portion   627,000    596,000 
Advance investor deposit   150,000    150,000 
Accrued liabilities   592,000    950,000 
           
Total current liabilities   10,352,000    10,685,000 
           
Long-term liabilities:          
Operating lease liabilities – noncurrent   2,704,000    2,873,000 
Notes payable – net of current portion   331,000    348,000 
           
Total long-term liabilities   3,035,000    3,221,000 
           
TOTAL LIABILITIES  $13,387,000   $13,906,000 
           
SHAREHOLDERS’ EQUITY          
Series E Preferred Stock — no par value, 130,000 shares authorized, issued and outstanding at March 31, 2026 and December 31, 2025 (liquidation preference of $1,300,000)   1,004,000    976,000 
Series F Preferred Stock — no par value, 70,000 shares authorized, issued and outstanding at March 31, 2026 and December 31, 2025 (liquidation preference of $700,000)   540,000    525,000 
Common stock - no par value, 2,000,000,000 shares authorized, 2,608,705 and 2,601,788 shares issued and 2,604,279 and 2,597,362 shares outstanding at March 31, 2026 and December 31, 2025, respectively   27,891,000    27,891,000 
Additional paid-in-capital   7,712,000    7,711,000 
Accumulated deficit   (28,727,000)   (28,386,000)
Less: Treasury stock, 4,426 shares, at cost   (161,000)   (161,000)
           
TOTAL SHAREHOLDERS’ EQUITY   8,259,000    8,556,000 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $21,646,000   $22,462,000 

 

See accompanying notes to condensed consolidated unaudited financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

1 
Table of Contents

 

Yunhong Green CTI, LTD

Unaudited Condensed Consolidated Statements of Income (Loss)

 

   2026   2025 
  

For the Three Months Ended

March 31,

 
   2026   2025 
         
Net sales  $6,154,000   $4,802,000 
           
Cost of sales   5,138,000    3,936,000 
           
Gross profit   1,016,000    866,000 
           
Operating expenses:          
General and administrative   924,000    839,000 
Selling   37,000    35,000 
Advertising and marketing   153,000    170,000 
           
Total operating expenses   1,114,000    1,044,000 
           
Loss from operations   (98,000)   (178,000)
           
Other (expense) income:          
Interest expense   (242,000)   (237,000)
Other (expense) / income   (1,000)   (1,000)
           
Total other (expense) / income, net   (243,000)   (238,000)
           
Net loss  $(341,000)  $(416,000)
           
Deemed dividends on preferred stock  $(43,000)  $(43,000)
           
Net loss attributable to Yunhong Green CTI Ltd common shareholders  $(384,000)  $(459,000)
           
Basic income (loss) per common share  $(0.15)  $(0.18)
           
Diluted income (loss) per common share  $(0.15)  $(0.18)
           
Weighted average number of shares and equivalent shares of common stock outstanding:          
Basic   2,600,501    2,600,658 
           
Diluted   2,600,501    2,600,658 

 

See accompanying notes to condensed consolidated unaudited financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

2 
Table of Contents

 

Yunhong Green CTI, Ltd

Unaudited Condensed Consolidated Statements of Cash Flows

 

   2026   2025 
   For the Three Months Ended March 31, 
   2026   2025 
         
Cash flows from operating activities:          
Net loss  $(341,000)  $(416,000)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization   150,000    163,000 
Equity compensation charge   44,000    9,000 
           
Change in assets and liabilities:          
Accounts receivable   (154,000)   772,000 
Inventories   732,000    (175,000)
Prepaid expenses and other assets   45,000    63,000 
Trade payables   105,000    334,000 
Operating leases   13,000    - 
Accrued liabilities   (358,000)   220,000 
           
Net cash provided by operating activities   236,000    970,000 
           
Cash flows from investing activities:          
Purchases of property, plant and equipment   (27,000)   (20,000)
           
Net cash used in investing activities   (27,000)   (20,000)
           
Cash flows from financing activities:          
Repayment of note payable   (14,000)   (21,000)
Net advances (repayments) on revolving line of credit   (114,000)   (977,000)
           
Net cash used in financing activities   (128,000)   (998,000)
           
Net increase (decrease) in cash and cash equivalents   81,000    (48,000)
           
Cash and cash equivalents at beginning of period   97,000    220,000 
           
Cash and cash equivalents at end of period  $178,000   $172,000 
           
Supplemental disclosure of cash flow information and noncash investing and financing activities:          
Cash payments for interest  $242,000   $237,000 
Accretion of dividends on preferred stock   43,000    43,000 
Common stock issued in exchange for rent due to Icy Melon   -    182,000 

 

See accompanying notes to condensed consolidated unaudited financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

3 
Table of Contents

 

Yunhong Green CTI, Ltd

Unaudited Condensed Consolidated Statements of Shareholders’ Equity

 

   Shares   Amount   Shares   Amount   Shares   Amount  

Capital

   Earnings   Shares   Amount   TOTAL 
  

Series E

Preferred Stock

  

Series F

Preferred Stock

   Common Stock  

Additional

Paid-in

  

Accumulated

(Deficit)

   Less
Treasury Stock
     
   Shares   Amount   Shares   Amount   Shares   Amount  

Capital

   Earnings   Shares   Amount   TOTAL 
                                             
Balance December 31, 2025   130,000   $976,000    70,000   $525,000    2,601,788   $27,891,000   $7,711,000   $(28,386,000)   (4,426)  $(161,000)  $8,556,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000         -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Equity Compensation Charge        -    -    -              6,000    -    -    -    6,000 
Stock Issuance - Vesting Milestone                       6,917         38,000                   38,000 
Net Loss   -    -    -    -    -    -         (341,000)   -    -    (341,000)
                                                      - 
Balance March 31, 2026   130,000   $1,004,000    70,000   $540,000    2,608,705   $27,891,000   $7,712,000   $(28,727,000)   (4,426)  $(161,000)  $8,259,000 

 

Yunhong Green CTI, Ltd

Unaudited Condensed Consolidated Statements of Shareholders’ Equity

 

  

Series E

Preferred Stock

  

Series F

Preferred Stock

   Common Stock  

Additional 

Paid-in
  

Accumulated

(Deficit)

   Less
Treasury Stock
     
   Shares   Amount   Shares   Amount   Shares   Amount  

Capital

   Earnings   Shares   Amount   TOTAL 
                                             
Balance December 31, 2024   130,000   $864,000    70,000   $465,000    2,599,185   $27,533,000   $7,858,000   $(25,856,000)   (4,426)  $(161,000)  $10,703,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000         -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Common Stock Issuance for Rent        -    -    -    27,604    182,000    -    -    -    -    182,000 
Equity Compensation Charge   -    -    -    -    -    -    9,000    -    -    -    9,000 
Net Loss   -    -    -    -    -    -    -    (416,000)   -    -    (416,000)
                                                        
Balance March 31, 2025   130,000   $892,000    70,000   $480,000    2,626,789   $27,715,000   $7,824,000   $(26,272,000)   (4,426)  $(161,000)  $10,478,000 

 

See accompanying notes to condensed consolidated unaudited financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

4 
Table of Contents

 

Yunhong Green CTI Ltd.

Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1 - Basis of Presentation and Significant Accounting Policies

 

The accompanying unaudited condensed consolidated interim financial statements have been prepared and, in the opinion of management, contain all material adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of income (loss) and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X.

 

Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025, filed on March 23, 2026, which can be found on the Company’s website (www.ctiindustries.com) or www.sec.gov.

 

The financial information presented in these financial statements has been rounded to the nearest thousand dollars ($000), which is in accordance with our policy to simplify the presentation. The financial information is not presented in thousand-dollar increments.

 

All of the Company’s historical share and per share information related to issued and outstanding common stock, outstanding share based awards and warrants exercisable for common stock in these financial statements have been adjusted, on a retroactive basis, to reflect the 1-for-10 reverse stock split approved by the Company’s shareholders on August 22, 2025 and effective October 1, 2025.

 

Principles of consolidation and nature of operations:

 

Yunhong Green CTI Ltd., its wholly owned subsidiary Yunhong Technology Industry (Hubei) Co., Ltd., and its inactive subsidiary CTI Supply, Inc. (collectively, the “Company”) (i) design, manufacture and distribute metalized balloon products throughout the world, (ii) distribute purchased latex balloons products, and (iii) operate systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

 

The condensed consolidated financial statements include the accounts of Yunhong Green CTI Ltd., CTI Supply, Inc., and Yunhong Technology Industry (Hubei) Co., Ltd. All intercompany accounts and transactions have been eliminated in consolidation. See Note 2 Form 10-K for the fiscal year ended December 31, 2025.

 

Use of estimates:

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include recoverability and impairment of long-lived assets, valuation allowances for doubtful accounts, inventory valuation, and valuation of deferred tax assets.

 

Segments:

 

The Company views its operations and manages its business as one segment, both in terms of geography and operations. All manufacturing occurs in the United States. Due to the single reportable segment, this financial information is presented on the Consolidated Statements of Income (Loss). There are no significant segment expenses reported to the chief operating decision maker (CODM), which is the Chief Executive Officer. The Company’s CODM regularly reviews financial information presented and does not evaluate the Company’s operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.

 

5 
Table of Contents

 

Earnings per share:

 

Basic (loss) per share is computed by dividing net loss attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period.

 

Diluted (loss) per share is computed by dividing the net loss attributable to common shareholders by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period. In periods for which there is a net loss, diluted loss per common share is equal to basic loss per common share, since the effect of including any common stock equivalents would be antidilutive.

 

For both March 31, 2026 and 2025, shares to be issued upon the exercise of warrants aggregated 55,600. No options were outstanding for the three months ended March 31, 2026 and 2025. The number of shares included in the determination of earnings on a diluted basis for the three months ended March 31, 2026 and 2025 were none, as doing so would have been anti-dilutive.

 

Revenue recognition:

 

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales, as we have elected the practical expedient included in ASC 606.

 

The Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed by governmental authorities are accounted for on a net basis and are excluded from net sales.

 

Note 2 Liquidity and Going Concern

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has a cumulative net loss from inception to March 31, 2026 of approximately $29 million. The accompanying financial statements for the three months ended March 31, 2026 have been prepared assuming the Company will continue as a going concern. The Company’s cash resources from operations may be insufficient to meet its anticipated needs during the next twelve months. If the Company does not execute its plan, it may require additional financing to fund its future planned operations.

 

The ability of the Company to continue as a going concern is dependent on the Company having adequate capital to fund its operating plan and performance. Management’s plans to continue as a going concern may include raising additional capital through sales of equity securities and borrowing, continuing to focus our Company attaining profitable operations, and exploring alternative funding sources on an as needed basis. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. The supply chain challenges, inflationary pressures and tariffs have impacted on the Company’s business operations to some extent and is expected to continue to do so and these impacts may include reduced access to capital. The ability of the Company to continue as a going concern may be dependent upon its ability to successfully secure other sources of financing and attain profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under a Credit Agreement. The Credit Agreement with Line Financial, as most recently amended in September 2025, includes a revolving credit facility for up to $7 million and a term loan of $0.7 million, all supported by the majority of our assets. This Agreement was extended during September 2025, to mature April 30, 2027, under substantially similar terms.

 

6 
Table of Contents

 

Note 3 – Debt

 

Senior Facilities

 

On September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”) with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility (the “Revolving Credit Facility) in an aggregate principal amount of up to $7 million, as amended (the “Maximum Revolver Amount”), subject to borrowing base provisions, and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $731,250 (“Term Loan Amount” and, together with the Revolving Credit Facility, the “Senior Facilities”). The Senior Facilities are secured by substantially all assets of the Company. The Company has remained in compliance with all material covenants since inception.

 

Borrowings under the Revolving Credit Facility bear interest at the prime rate + 7.82% (14.57% as of March 31, 2026), payable monthly in arrears. The Term Loan Facility bears interest at the prime rate + 1.45% (8.2% as of March 31, 2026) and is repaid in 48 monthly installments of approximately $15,000, beginning November 1, 2021. The Company also pays collateral monitoring fees of 4.62% of the eligible accounts receivable, inventory, and equipment supporting both facilities.

 

Originally maturing September 30, 2023, the Senior Facilities were extended to April 30, 2027 pursuant to a Fifth Amendment executed on September 30, 2025, which also increased the revolving commitment from $6.0 million to $7.0 million and added a 0.75% renewal fee, payable in two equal installments in October 2025 and September 2026. A $12,500 commitment fee was also incurred. All other material terms, including borrowing base, collateral, and covenants, remained unchanged.

 

The facility automatically renews for successive one-year periods unless either party provides written notice of termination not less than 90 days prior to the end of the then-current term. The Company may prepay the Term Loan Facility (together with accrued interest and any applicable prepayment fee) in whole, but not in part, upon at least 60 days’ prior written notice.

 

The Agreement requires the Company to maintain minimum tangible net worth of $4.0 million, subject to adjustment by the Lender. The Company was in compliance with this covenant as of March 31, 2026 and 2025. The Agreement also limits additional indebtedness, liens, dividends, mergers, and annual capital expenditures exceeding $1.0 million.

As of March 31, 2026 and December 31, 2025, the term loan balance was approximately $0.5 and $0.5 million, respectively, and the revolving balance was $6.7 million and $6.8 million, respectively. There was $0.3 million remaining available for borrowing under the Revolving Credit Facility as of March 31, 2026.

Notes payable, Related Party

 

The Company is party to a note payable to John H. Schwan, Director and former Chairman of the Board, for an initial amount of $1.3 million as of December 31, 2023 and an interest rate of 6%. The Company repaid $1 million to Mr. Schwan during January 2024. The parties agreed to the payment of the remaining $0.3 million at a future date to be determined. This related party note payable is subordinate to the Senior Facilities.

 

7 
Table of Contents

 

Note 4 - Shareholders’ Equity

 

Series E Convertible Preferred Stock

 

The Company’s Articles of Incorporation, as amended, authorized the issuance of 130,000 shares of Series E Convertible Preferred Stock (“Series E Preferred”). The Series E Preferred can be converted to common stock based on meeting certain conditions set forth in the document at ten (10) shares of the company’s common stock, no par value. Holders of the Series E Preferred will be entitled to receive quarterly dividends at the annual rate of 8.5% of the stated value ($10 per share) and have a liquidation preference over common stock. Such dividends may be paid in cash or otherwise based on the terms of the agreement. Accrued dividends of $233,000 and $205,000 were recorded as of March 31, 2026 and December 31, 2025, respectively. In addition, warrants to purchase 36,140 shares of the Company’s common stock were issued with respect to this transaction and are equity classified instruments. These warrants are exercisable until March 2027.

 

Series F Convertible Preferred Stock

 

The Company’s Articles of Incorporation, as amended, authorized the issuance of 70,000 shares of Series F Preferred. The Series F Preferred can be converted to common stock were issued with respect to this transaction. Holders of the Series F Preferred will be entitled to receive quarterly dividends at the annual rate of 8.5% of the stated value ($10 per share) and have a liquidation preference over common stock. Such dividends may be paid in cash or stock, at the Company’s discretion, based on the terms of the agreement. Accrued dividends of $125,000   and $110,000 were recorded as of March 31, 2026 and December 31, 2025, respectively. In addition, warrants to purchase 19,460 shares of the Company’s common stock were issued with respect to this transaction and are equity classified instruments. These warrants are exercisable until March 2027.

 

Warrants

 

As described above, in connection with the Series E and F convertible preferred equity issuances, a total of 55,600 warrants were issued, exercisable for the Company’s common stock at the lower of $15.2 per share or 90% of the 10 day VWAP.

 

8 
Table of Contents

 

A summary of the Company’s stock warrant activity is as follows:

 

   Shares under
Option (warrant)
   Weighted Average
Exercise Price
 
Balance at December 31, 2025   55,600   $15.2 
Granted   -    - 
Cancelled/Expired   -    - 
Exercised/Issued   -    - 
Outstanding at March 31, 2026   55,600    15.2 
           
Exercisable at March 31, 2026   55,600   $15.2 

 

As of March 31, 2026, the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock:

 

 

2025 Common Stock Warrants   55,600 
Shares reserved as of March 31, 2026   55,600 

 

Security 

Preferred Shares

Authorized/

Outstanding

   Conversion Ratio  

Common Shares

Reserved

 
Series E Preferred Stock   130,000    10:01    1,300,000 
Series F Preferred Stock   70,000    10:01    700,000 
Shares reserved for Preferred Stock as of March 31, 2026             2,000,000 

 

Restricted Stock Awards

 

Restricted Stock Units, Performance-Based Restricted Stock Units and Restricted Stock Awards:

Aggregated information regarding RSUs, PSUs and RSAs granted under the Plan is summarized below:

 

   RSUs, PSUs & RSAs  

Weighted

Average Grant-

Date Fair Value

 
Outstanding, unvested at December 31, 2025   20,158    3.63 
Granted   -    -  
Vested   (6,804)   6.47 
Forfeited   -    -  
Outstanding, unvested at March 31, 2026   13,354    2.78 

 

Differences between amount of vested awards and shares of common stock issued are attributable to timing differences.

 

Note 5 - Legal Proceedings

 

The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

 

9 
Table of Contents

 

Note 6 - Inventories

 

   March 31, 2026   December 31, 2025 
Raw materials  $974,000   $749,000 
Work in process   2,534,000    2,569,000 
Finished goods   4,498,000    5,420,000 
Total inventories  $8,006,000   $8,738,000 

 

Note 7 - Concentration of Credit Risk

 

Concentration of credit risk with respect to trade accounts receivable is generally limited due to the large number of entities comprising the Company’s customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management’s expectations.

 

During the three months ended March 31, 2026 and 2025, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three months ended March 31, 2026 and 2025 are as follows:

 

   Three Months Ended   Three Months Ended 
   March 31, 2026   March 31, 2025 
Customer  Net Sales  

% of Net

Sales

   Net Sales  

% of Net

Sales

 
Customer A  $2,378,000    39%  $3,091,000    64%
Customer B  $2,969,000    48%  $523,000    11%

 

As of March 31, 2026, the outstanding accounts receivable balance from these customers was $6 million.

 

Note 8 - Related Party Transactions

 

Ms. Jana M. Schwan is the Company’s Chief Executive Officer. Her father, John H. Schwan, held several positions with the Company over many years, most recently as Chairman of the Board until June 2020 as discussed in Note 3, Mr. John H. Schwan was owed approximately $0.3 million as of both March 31, 2026 and December 31, 2025, in a note from the Company.

 

Icy Mellon LLC, the landlord of the Company’s Barrington Facility, is a shareholder of the Company. On January 13, 2025, the Company issued 27,604 shares of common stock   with an aggregate fair value of approximately $182,000 to settle rent payable that had been included in accrued expenses as of December 31, 2024. Barrington rent expense totaled approximately $141,000 and $137,000   for the three months ended March 31, 2026, and 2025, respectively. As of March 31, 2026 and December 31, 2025, amounts due to Icy Mellon LLC totaled approximately $234,000 and $234,000  . The Company’s Vice President – Strategy and Business Development also serves as a Manager of Icy Mellon LLC.

 

Note 9 - Leases

 

We entered into lease contracts for certain of our facilities at two locations. Our leases have remaining lease terms of two and five years.

 

The weighted average discount rate for our operating leases is 14.05%. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

 

At March 31, 2026, maturities of operating lease liabilities are as follows:

 

      
2026  $789,000 
2027   1,083,000 
2028   1,119,000 
2029   627,000 
2030   646,000 
Thereafter   217,000 
Total Lease Payments   4,481,000 
Less: Imputed interest   (1,150,000)
Total Lease Liabilities  $3,331,000 

 

Note 10 – Subsequent Events

 

On April 22, 2026, the Board of Directors of Yunhong Green CTI Ltd. Appointed Fred H. F. Chak, an existing member of the Board, to serve as the Chairman of the Board, effective April 27, 2026. Mr. Chak succeeds Gerald D. Roberts Jr., who has served as interim Chairman of the Board since February 17, 2026. Mr. Roberts will continue to serve as a director of the company.

 

10 
Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Note Regarding Forward Looking Statements

 

This Quarterly Report on Form 10-Q includes both historical and “forward-looking statements” within the meaning of federal securities law. All such statements are qualified by this cautionary note, which is provided pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this Quarterly Report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this Quarterly Report on Form 10-Q to conform such statements to actual results or to changes in our opinions or expectations. These forward-looking statements are affected by factors, risks, uncertainties and assumptions that we make, including, without limitation, those discussed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 under the heading “Risk Factors.”

 

Overview

 

We produce film products for novelty, packaging and container applications. These products include foil balloons, latex balloons and related products, films for packaging and custom product applications, and flexible containers for packaging and consumer storage applications. We produce all of our film products for packaging, container applications and most of our foil balloons at our plant in Lake Barrington, Illinois. The Company purchases latex balloons from an unrelated vendor and distributes in the United States, particularly to those customers that prefer a combined solution for foil and latex balloons. Substantially all our film products for packaging and custom product applications are sold to customers in the United States. We market and sell our novelty items, Balloon inspired gifts (balloons and candy arranged to look like a flower bouquet for gifting) and flexible containers for consumer use primarily in the United States. The Company incorporated “Green” into the Company name to communicate our intention to supply biodegradable and compostable materials to the marketplace that are developed by our partners in Asia. We created a new subsidiary, in part, for this purpose. In recent periods, the U.S. government has imposed tariffs on certain goods imported from countries including China. Existing and future trade tariffs, import duties and quotas could also materially increase our costs of procuring the materials we use and disrupt the markets for the products we handle, which in turn could have a material adverse effect on our financial position, results of operations and cash flows.

 

Senior Credit Facilities

 

As of March 31, 2026  , the Company maintained senior secured credit facilities with Line Financial, consisting of a $7.0 million revolving credit facility and a $0.7   million term loan. The facilities are secured by substantially all Company assets.

 

Borrowings under the Revolving Credit Facility bear interest at the prime rate + 7.82% (14.57% as of March 31, 2026 while the term loan bears interest at the prime rate plus 1.45% and is repaid in monthly installments of approximately $15,000. The facilities include standard financial and operational covenants, including a minimum tangible net worth requirement of $4.0 million, with which the Company was in compliance as of March 31, 2026.  

 

In September 2025, the Company executed a Fifth Amendment extending maturity to April 30, 2027, and increasing the revolving commitment from $6.0 million to $7.0 million. The amendment also introduced a 0.75% renewal fee payable in two equal installments (October 2025 and September 2026) and a $12,500 commitment fee associated with the expanded facility.

 

At March 31, 2026, the company had $6.7 million outstanding on the revolving facility and $0.5 million on the term loan, with $0.3 million of remaining borrowing capacity.

 

11 
Table of Contents

 

Note Payable, Related Party

 

The Company also has a subordinated note payable to Director and former Chairman John H. Schwan bearing 6% interest, with a balance of $0.3 million remaining after a $1.0 million repayment in January 2024.

 

Results of Operations

 

Net Sales: Net sales for the three-month periods ended March 31, 2026 and 2025 were approximately $6.2 million and $4.8 million, respectively, representing an increase of $1.4 million, or 28% year-over-year.

 

For the three-month period ended March 31, 2026 and 2025, net sales by product category were as follows:

 

   Three Months Ended         
   March 31, 2026   March 31, 2025         
                         
Product Category   

$
(000)

Omitted

    % of
Net Sales
    

$
(000)

Omitted

    % of
Net Sales
    Variance    %
change
 
                               
Foil Balloons  $3,487    57%  $4,234    88%  $(747)   -18%
                               
Film Products   39    0%   427    9%   (388)   -91%
                               
Other   2,628    43%   141    3%   2,487    1764%
                               
Total  $6,154    100%  $4,802    100%  $1,352    28%

 

Foil Balloons. Revenues from the sale of foil balloons decreased during the three-month period ended March 31, 2026 to $3,487,000 compared to $4,234,000 during the same period of 2025. The decrease is related to the timing of orders and shipments. In the second half of 2025 one of our large mass retail customers made some adjustments to their replenishment system due to a surplus in their supply chain.

 

Films. Revenues from the sale of commercial films decreased during the three-month period ended March 31, 2026 to $39,000 compared to $427,000 during the same period of 2025. Sales in this area have been inconsistent due to a small number of customers and a significant number of competitors.

 

Other Revenues: Other revenues increased to $2,628,000 for the three-month period ended March 31, 2026, compared to $141,000 for the same period in 2025. The primary reason for the increase was the timing of spring product shipments, which occurred in first quarter of 2026 rather than the second quarter in 2025. Other revenues during these periods primarily consisted of: (i) sales of balloon-inspired gift products, including candy and small inflated balloons packaged in small containers; and (ii) sales of accessories and supply items related to balloon products. Sales to a limited number of customers continue to represent a large percentage of our net sales.

 

The table below illustrates the impact on sales of our top three and ten customers for the three-month periods ended March 31, 2026 and 2025.

 

   Three Months Ended March 31, 
   % of Sales 
   2026   2025 
         
Top 3 Customers   90%   81%
           
Top 10 Customers   95%   93%

 

12 
Table of Contents

 

During the three-month period ended March 31, 2026, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three-month period ended March 31, 2026 were $2,378,000 and $2,969,000 or 39% and 48   %, respectively of consolidated net sales. Sales to these customers for the three months ended March 31, 2025 were $3,091,000 and $523,000, or 64% and 11%, respectively of consolidated net sales. As of March 31, 2026, the total amount owed to the Company by these customers was approximately $6,056,000, or 99% of the Company’s consolidated net accounts receivable.

 

Cost of Sales. During the three-month period ended March 31, 2026, the cost of sales was $5,138,000, compared to $3,936,000 for the same period of 2025. The gross margin for March 31, 2026 is 17% compared to 18% for the same period of 2025, the decrease in gross margin is related to increase in component prices and raw materials due to escalating fuel prices.

 

General and Administrative. During the three-month period ended March 31, 2026, general and administrative expenses were $924,000 as compared to $839,000 for the same period in 2025. The largest increase is attributed to increase in audit fee of $65k and increases in variable rent expenses.

 

Selling, Advertising and Marketing. During the three-month period ended March 31, 2026, selling, advertising and marketing expenses were $190,000 as compared to $205,000 for the same period in 2025.

 

Other Income (Expense). During the three-month period ended March 31, 2026, the Company incurred interest expense of $242,000 as compared to interest expense of $237,000 during the same period of 2025.

 

Financial Condition, Liquidity and Capital Resources

 

Cash Flow Items.

 

Operating Activities. During the three months ended March 31, 2026, net cash provided by operations was $236,000, compared to net cash provided in operations during the three months ended March 31, 2025 of $970,000.

 

Significant changes in working capital items during the three months ended March 31, 2026 included:

 

  An increase in accounts receivable of $154,000 compared to a decrease in accounts receivable of $772,000 in the same period of 2025.
     
  A decrease in inventory of $732,000 compared to an increase in inventory of $175,000 in 2025.
     
  An increase in trade payables of $105,000 compared to an increase in trade payables of $334,000 in 2025.
     
  A decrease in prepaid expenses and other assets of $45,000 compared to a decrease of $63,000 in 2025.
     
  A decrease in accrued liabilities of $358,000 compared to an increase in accrued liabilities of $220,000 in 2025.

 

Investing Activity. During the three months ended March 31, 2026, cash used in investing activity was $27,000, compared to cash used in investing activity for the same period of 2025 in the amount of $20,000.

 

Financing Activities. During the three months ended March 31, 2026, cash used in financing activities was $128,000 compared to cash used in financing activities for the same period of 2025 in the amount of $998,000. Financing activity during 2026 consisted principally of changes in the balances of revolving and long-term debt.

 

Liquidity and Capital Resources.

 

At March 31, 2026, the Company had cash balances of $178,000 compared to cash balances of $172,000 for the same period of 2025.

 

13 
Table of Contents

 

The ability of the Company to continue as a going concern is dependent on the Company executing its business plan and, if unable to do so, in obtaining adequate capital on acceptable terms to fund any operating losses. Management’s plans to continue as a going concern include executing its business plan, continuing to focus on achieving profitable operations, and exploring alternative funding sources on an as needed basis. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. The supply chain constraints, inflationary pressures and tariffs are expected to impact to some extent our operations and reduced access to capital. The ability of the Company to continue as a going concern is dependent upon its ability to successfully generate or otherwise secure other sources of financing and attain profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under the Credit Agreement. While the Company expects to have access to needed capital at reasonable cost, there can be no assurance of success, and as such, might negatively impact the Company’s ability to continue as a going concern.

 

Seasonality

 

In the foil balloon product line, sales have historically been seasonal with approximately 40% occurring in the period from December through March of the succeeding year and 24% being generated in the period July through October in recent years.

 

Critical Accounting Estimates

 

The critical accounting estimates utilized by the Company in preparation of the accompanying financial statements are set forth in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. There have been no material changes to these policies since December 31, 2025.

 

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

(a) Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified by the Commission’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are properly recorded, processed, summarized and reported within the time periods required by the Commission’s rules and forms.

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer), of the effectiveness of the design and operation of these disclosure controls and procedures, as such term is defined in Exchange Act Rule 13a-15(e), as of March 31, 2026. Based on this evaluation, the Chief Executive Officer (principal executive officer) concluded that our disclosure controls and procedures were not effective as of March 31, 2026, the end of the period covered by this Quarterly Report on Form 10-Q, due to the material weaknesses described below.

 

14 
Table of Contents

 

(b) Management’s Report on Internal Control over Financial Reporting

 

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness of internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management has assessed the effectiveness of our internal control over financial reporting as of March 31, 2026. In making our assessment of the effectiveness of internal control over financial reporting, management used the criteria set forth in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

A material weakness is a control deficiency, or combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis. As a result of our evaluation of our internal control over financial reporting, management identified the following material weaknesses in our internal control over financial reporting:

 

  We lack a sufficient number of accounting professionals with the necessary knowledge, experience and training to adequately account for the application of new accounting standards as well as significant, unusual transactions particularly with regard to equity financing arrangements and the timing of recognition of certain non-cash charges.

 

Accordingly, management concluded that we did not maintain effective internal control over financial reporting as of March 31, 2026.

 

Plan for Remediation of Material Weakness

 

The Company believes that the combination of responsibilities held by the Chief Executive Officer and the Corporate Controller strengthens financial oversight, enhances internal control effectiveness, and promotes leadership continuity. As management continues to evaluate and refine our internal control framework, additional steps may be taken to address any remaining deficiencies or to further strengthen and remediation measures already in place.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by its registered public accounting firm pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, which permits the Company to provide only management’s report in this quarterly report.

 

(c) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 5.02 - Departure of Directors or Certain Officers; Election of Directors  

 

On January 19, 2026, Philip Wong notified the Board of Directors of his resignation as Director, effective immediately, due to personal reasons. Mr. Wong’s departure was not due to any disagreement with the Company on any matter relating to its operations, policies, or practices.

 

On January 22, 2026, Iris Chan was elected as an Independent Director and Audit Committee Chair for the vacant term to conclude upon the election of directors during the 2026 Annual Meeting of Shareholders.

 

On February 17, 2026, Yubao Li notified the Board of Directors of his resignation as the Chairman and Director, effective immediately, due to personal reasons. Mr. Li’s departure was not due to any disagreement with the Company on any matter relating to its operations, policies, or practices.

 

On February 17, 2026, Gerald D. Roberts Jr. was elected as interim Chairman. Mr. Roberts has agreed to serve until a permanent Chairman is selected.

 

On March 27, 2026, Fred H.F. Chak was elected by the Board of Directors as an Independent Director effective immediately.

 

15 
Table of Contents

 

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

 

Item 1A. Risk Factors

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

16 
Table of Contents

 

Item 6. Exhibits

 

The following are being filed as exhibits to this report:

 

Exhibit

Number

  Description
     
31.1*   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
31.2*   Certification of Corporate Controller and Principal Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
32**   Certification of Chief Executive Officer, Corporate Controller and Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101*   Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in inline XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Consolidated Financial Statements.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
     
*   Filed herewith
**   furnished herewith

 

17 
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 13, 2026 Yunhong Green CTI Ltd.
   
  By: /s/ Jana M. Schwan
    Jana M. Schwan
    Chief Executive Officer
     
  By: /s/ Sree Kommana
    Sree Kommana
    Corporate Controller and Principal Financial Officer

 

18